Anna Mazzetto

Dr. Anna Mazzetto

Università di Padova
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
ACAlessandro Camerotto
Alessandro Camerotto
ASAndrea Sartorio
Andrea Sartorio
Anna MazzettoAnna Mazzetto
Anna Mazzetto
MGMilena Gusella
Milena Gusella
OLOrnella Luppi
Ornella Luppi
ACAntonio Compostella
Antonio Compostella
The first cases of Coronavirus disease-2019 (COVID-19) were reported on 21 February in the small town of Vo’ near Padua in the Veneto region of Italy. This event led to 19,286 infected people in the region by 30 June 2020 (39.30 cases/10,000 inhabitants). Meanwhile, Rovigo Local Health Unit n. 5 (ULSS 5), bordering areas with high epidemic rates and having one of the world’s oldest populations, registered the lowest infection rates in the region (19.03 cases/10,000 inhabitants). The aim of this study was to describe timing and event management by ULSS 5 in preventing the propagation of infection within the timeframe spanning from 21 February to 30 June. Our analysis considered age, genetic clusters, sex, orography, the population density, pollution, and economic activities linked to the pandemic, according to the literature. The ULSS 5 Health Director General’s quick decision-making in the realm of public health, territorial assistance, and retirement homes were key to taking the right actions at the right time. Indeed, the number of isolated cases in the Veneto region was the highest among all the Italian regions at the beginning of the epidemic. Moreover, the implementation of molecular diagnostic tools, which were initially absent, enabled health care experts to make quick diagnoses. Quick decision-making, timely actions, and encouraging results were achieved thanks to a solid chain of command, despite a somewhat unclear legislative environment. In conclusion, we believe that the containment of the epidemic depends on the time factor, coupled with a strong sense of awareness and discretion in the Health Director General’s decision-making. Moreover, real-time communication with operating units and institutions goes hand in hand with the common goal of protecting public health.

10 April 2026 in Bleeding, Thrombosis and Vascular Biology
Verified
Journal Article
Open access
Anna MazzettoAnna Mazzetto
Anna Mazzetto
ACAlessandro Camerotto
Alessandro Camerotto
Inappropriateness in medical decision-making remains a persistent challenge, particularly in laboratory medicine. This phenomenon is largely driven by cognitive inadequacy, defined as the growing mismatch between the exponential expansion of medical knowledge and the limited capacity of human cognition to assimilate and apply it in real time. Artificial intelligence (AI), especially in its narrow form, designed and trained to perform specialized tasks, offers practical tools to mitigate this gap. This article examines the potential role of AI in improving prescription appropriateness in laboratory medicine, with a focus on coagulation diagnostics, and proposes a novel AI-based system that supports physicians at the point of decision-making through the use of curated, expert-annotated data.